Veterinary Medicine Segmentation
The veterinary medicine market is segmented by end-user into veterinary hospitals, veterinary clinics, and pharmacies. Out of which, the veterinary hospital sub-segment is anticipated to hold the largest share in the market on account of the large number of pet owners visiting the veterinary hospitals. On the back of aggressive research and technological advancement in the veterinary sector, the market is estimated to grow during the forecast period.
Our in-depth analysis of the global market includes the following segments:
|
Vaccines |
|
|
Medicated Feed Additives |
|
|
Route of Administration |
|
|
Animal Type |
|
|
End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of veterinary medicine is assessed at USD 54.45 billion.
Veterinary Medicine Market size was valued at USD 50.82 billion in 2024 and is expected to reach USD 145.02 billion by 2037, expanding at around 8.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is set to hold largest revenue share by 2037, on the back of escalating adoption of the animals in the region.
The major players in the market are Vetoquinol SA, Bayer AG, Bimeda Holdings PLC, Nutreco N.V., and Hester Biosciences Limited.
